• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外以及人头颈部癌的离体模型中靶向照射诱导的丝裂原活化蛋白激酶激活。

Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancer.

作者信息

Affolter Annette, Muller Marie-France, Sommer Katharina, Stenzinger Albrecht, Zaoui Karim, Lorenz Katja, Wolf Thomas, Sharma Sarika, Wolf Janina, Perner Sven, Weber Klaus-Josef, Freier Kolja, Plinkert Peter K, Hess Jochen, Weichert Wilko

机构信息

Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.

Department of Otorhinolaryngology, Head and Neck Surgery, Experimental Head and Neck Oncology, Heidelberg University Hospital, Heidelberg, Germany.

出版信息

Head Neck. 2016 Apr;38 Suppl 1:E2049-61. doi: 10.1002/hed.24376. Epub 2016 Feb 26.

DOI:10.1002/hed.24376
PMID:26918677
Abstract

BACKGROUND

Despite new radiotherapeutic strategies, radioresistance in head and neck squamous cell carcinoma (HNSCC) remains a major problem. Preclinical model systems are needed to identify resistance mechanisms in this heterogeneous entity.

METHODS

We elucidated the interplay among mitogen-activated protein kinase (MAPK)-inhibition, radiation, and p53 mutations in vitro and in a novel ex vivo model derived from vital human HNSCC samples. HNSCC cell lines (p53WT/mut) were treated with the mitogen-activated protein kinase (MEK)-inhibitor PD-0325901 and subsequently irradiated. Radiosensitization was functionally assessed and evaluated in the ex vivo model.

RESULTS

We observed a pronounced irradiation-induced extracellular signal-regulated kinase (ERK) phosphorylation in 2 cell lines, which was independent of their p53 mutation status and associated with PD-0325901-related radiosensitization in a clonogenic assay. Heterogeneity in irradiation-induced ERK phosphorylation and in radiosensitization after MEK-inhibition was also reflected in the ex vivo model.

CONCLUSION

We provide experimental evidence for radiosensitizing effects of PD-0325901 in HNSCC. The ex vivo culture technology might offer a promising tool for individualized drug efficacy testing. © 2016 Wiley Periodicals, Inc. Head Neck 38: E2049-E2061, 2016.

摘要

背景

尽管有新的放射治疗策略,但头颈部鳞状细胞癌(HNSCC)的放射抗性仍然是一个主要问题。需要临床前模型系统来确定这种异质性实体中的抗性机制。

方法

我们在体外以及源自活体人类HNSCC样本的新型离体模型中阐明了丝裂原活化蛋白激酶(MAPK)抑制、辐射和p53突变之间的相互作用。用丝裂原活化蛋白激酶(MEK)抑制剂PD - 0325901处理HNSCC细胞系(p53野生型/突变型),随后进行照射。在离体模型中对放射增敏作用进行功能评估和评价。

结果

我们在2种细胞系中观察到明显的辐射诱导的细胞外信号调节激酶(ERK)磷酸化,这与它们的p53突变状态无关,并且在克隆形成试验中与PD - 0325901相关的放射增敏作用有关。离体模型也反映了辐射诱导的ERK磷酸化和MEK抑制后放射增敏的异质性。

结论

我们提供了PD - 0325901对HNSCC有放射增敏作用的实验证据。离体培养技术可能为个体化药物疗效测试提供一个有前景的工具。©2016威利期刊公司。头颈外科38:E2049 - E2061,2016年。

相似文献

1
Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancer.在体外以及人头颈部癌的离体模型中靶向照射诱导的丝裂原活化蛋白激酶激活。
Head Neck. 2016 Apr;38 Suppl 1:E2049-61. doi: 10.1002/hed.24376. Epub 2016 Feb 26.
2
MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.MEK抑制剂PD-0325901克服对PI3K/mTOR抑制剂PF-5212384的耐药性并增强对人头颈鳞状细胞癌的抗肿瘤作用。
Clin Cancer Res. 2015 Sep 1;21(17):3946-56. doi: 10.1158/1078-0432.CCR-14-3377. Epub 2015 May 14.
3
Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling.靶向 FAK 通过降低 Akt1 和 MEK1/2 信号来增敏三维培养的人头颈鳞癌细胞的放射敏感性。
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e669-76. doi: 10.1016/j.ijrobp.2012.01.065. Epub 2012 Apr 6.
4
Multikinase inhibitors sorafenib and sunitinib as radiosensitizers in head and neck cancer cell lines.多激酶抑制剂索拉非尼和舒尼替尼在头颈部癌细胞系中作为放射增敏剂的作用
Head Neck. 2017 Apr;39(4):623-632. doi: 10.1002/hed.24557. Epub 2017 Feb 21.
5
Activation of mitogen-activated protein kinase extracellular signal-related kinase in head and neck squamous cell carcinomas after irradiation as part of a rescue mechanism.作为挽救机制的一部分,头颈部鳞状细胞癌在放疗后丝裂原活化蛋白激酶细胞外信号相关激酶的激活。
Head Neck. 2011 Oct;33(10):1448-57. doi: 10.1002/hed.21623. Epub 2010 Nov 10.
6
Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer.联合放疗靶向作用于 MAPK 和 PI3K 信号通路治疗胰腺癌的策略。
Mol Cancer Ther. 2012 May;11(5):1193-202. doi: 10.1158/1535-7163.MCT-12-0098. Epub 2012 Mar 12.
7
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.SRC/ETS-1 信号通路调控顺铂耐药的头颈部鳞状细胞癌。
BMC Cancer. 2019 May 22;19(1):485. doi: 10.1186/s12885-019-5664-7.
8
MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer.MEK 抑制剂 PD-0325901 克服了对 CK2 抑制剂 CX-4945 的耐药性,并在头颈部癌症中显示出抗肿瘤活性。
Int J Biol Sci. 2015 Feb 23;11(4):411-22. doi: 10.7150/ijbs.10745. eCollection 2015.
9
Isoalantolactone Enhances the Radiosensitivity of UMSCC-10A Cells via Specific Inhibition of Erk1/2 Phosphorylation.异去甲莪术二酮通过特异性抑制Erk1/2磷酸化增强UMSCC-10A细胞的放射敏感性。
PLoS One. 2015 Dec 30;10(12):e0145790. doi: 10.1371/journal.pone.0145790. eCollection 2015.
10
Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384.双PI3K/mTOR抑制剂PF-05212384对头颈部鳞状细胞癌的放疗增敏作用
Clin Cancer Res. 2015 Jun 15;21(12):2792-801. doi: 10.1158/1078-0432.CCR-14-3279. Epub 2015 Feb 27.

引用本文的文献

1
MYC Overexpression Enhances Sensitivity to MEK Inhibition in Head and Neck Squamous Cell Carcinoma.MYC过表达增强头颈部鳞状细胞癌对MEK抑制的敏感性。
Int J Mol Sci. 2025 Jan 12;26(2):588. doi: 10.3390/ijms26020588.
2
Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes.标准疗法对头颈部癌细胞系和外泌体中 PD-L1 表达的调控。
Int J Oncol. 2023 Sep;63(3). doi: 10.3892/ijo.2023.5550. Epub 2023 Jul 28.
3
Targeted therapy for head and neck cancer: signaling pathways and clinical studies.
头颈部癌症的靶向治疗:信号通路与临床研究。
Signal Transduct Target Ther. 2023 Jan 16;8(1):31. doi: 10.1038/s41392-022-01297-0.
4
Precision Medicine Gains Momentum: Novel 3D Models and Stem Cell-Based Approaches in Head and Neck Cancer.精准医学蓬勃发展:头颈部癌症中的新型3D模型和基于干细胞的方法
Front Cell Dev Biol. 2021 Jul 8;9:666515. doi: 10.3389/fcell.2021.666515. eCollection 2021.
5
Mitogen-activated protein kinase inhibition-induced modulation of epidermal growth factor receptor signaling in human head and neck squamous cell carcinoma.丝裂原活化蛋白激酶抑制诱导的人头颈鳞状细胞癌表皮生长因子受体信号转导的调节。
Head Neck. 2021 Jun;43(6):1721-1729. doi: 10.1002/hed.26633. Epub 2021 Feb 3.
6
Ex Vivo Culture Models to Indicate Therapy Response in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌治疗反应的体外培养模型。
Cells. 2020 Nov 23;9(11):2527. doi: 10.3390/cells9112527.
7
Organotypic Co-Cultures as a Novel 3D Model for Head and Neck Squamous Cell Carcinoma.器官型共培养作为头颈部鳞状细胞癌的新型三维模型
Cancers (Basel). 2020 Aug 18;12(8):2330. doi: 10.3390/cancers12082330.
8
Dual effects of active ERK in cancer: A potential target for enhancing radiosensitivity.活性ERK在癌症中的双重作用:增强放射敏感性的潜在靶点。
Oncol Lett. 2020 Aug;20(2):993-1000. doi: 10.3892/ol.2020.11684. Epub 2020 May 28.
9
Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC.针对治疗的适应性 ERK 信号激活和头颈部鳞状细胞癌中 EGFR-MAPK 的计算机模拟预后评估。
Br J Cancer. 2020 Jul;123(2):288-297. doi: 10.1038/s41416-020-0892-9. Epub 2020 May 19.
10
Relevance of humanized three-dimensional tumor tissue models: a descriptive systematic literature review.人源化三维肿瘤组织模型的相关性:一项描述性系统文献回顾。
Cell Mol Life Sci. 2020 Oct;77(20):3913-3944. doi: 10.1007/s00018-020-03513-y. Epub 2020 Apr 13.